Astronauts will have to wait until next year before flying to the moon and another few years before landing on it, under the latest round of delays announced by NASA on Tuesday.

The space agency had planned to send four astronauts around the moon late this year, but pushed the flight to September 2025 because of technical issues. The first human moon landing in more than 50 years also got bumped, from 2025 to 2026.

The news came barely an hour after a Pittsburgh company abandoned its own attempt to land its spacecraft on the moon because of a mission-ending fuel leak.

Launched on Monday as part of NASA's commercial lunar program, Astrobotic Technology's Peregrine lander was supposed to serve as a scout for the astronauts. A Houston company will give it a shot with its own lander next month.

NASA is relying heavily on private companies for its Artemis moon-landing program for astronauts, named after the mythological twin sister of Apollo.

Share:
More In Business
Hard pass, Cold brew, Dad bod: Merriam-Webster adds 5,000 new words
Merriam-Webster has fully revised its popular “Collegiate” dictionary with over 5,000 new words. They include “petrichor,” “dumbphone” and “ghost kitchen.” Also “cold brew,” “rizz,” “dad bod,” “hard pass,” “cancel culture” and more.
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More